Dietary factors and risk of mortality among patients with esophageal cancer: A systematic review

The effects of dietary factors on prognosis of esophageal cancer remain unclear. This systematic review and meta-analysis aimed to assess the association between dietary intake and the risk of mortality among patients with esophageal cancer.

Sun et al BMC Cancer (2020) 20:287 https://doi.org/10.1186/s12885-020-06767-8 RESEARCH ARTICLE Open Access Dietary factors and risk of mortality among patients with esophageal cancer: a systematic review Li-Ping Sun1, Lu-Bin Yan2, Zhen-Zhen Liu3, Wen-Jing Zhao4, Cai-Xia Zhang1, Yu-Min Chen1, Xiang Qian Lao5 and Xudong Liu1* Abstract Background: The effects of dietary factors on prognosis of esophageal cancer remain unclear This systematic review and meta-analysis aimed to assess the association between dietary intake and the risk of mortality among patients with esophageal cancer Methods: Six electronic databases (PubMed, Web of Science, OVID, ProQuest, CNKI and Wanfang) were searched for studies published up to Oct 2019 that examined the association between dietary intake and all-cause mortality, esophageal cancer-specific mortality and esophageal cancer recurrence The pooled hazard ratio (HR) with 95% confidence interval (CI) were derived by comparing the highest with the lowest categories of each dietary item and by using random effect models Results: A total of 15 cohort studies were included in this study and all reported pre-diagnosis dietary exposure; two focused on dietary folate, 12 on alcohol consumption and three on other dietary components (sugary beverages, phytochemicals and preserved vegetables) When comparing the highest with the lowest categories, dietary folate intake was associated with a reduced risk of esophageal cancer-specific mortality in patients with esophageal squamous cell carcinoma (HR: 0.41, 95% CI: 0.25–0.69), with low heterogeneity (I2 = 0%, P = 0.788) When comparing the highest with the lowest categories of alcohol consumption, alcohol consumption was associated with an increased risk of all-cause mortality in patients with esophageal squamous cell carcinoma (HR: 1.29, 95% CI: 1.07–1.55; heterogeneity: I2 = 53%, P = 0.030), but this increased risk was not significant in patients with esophageal adenocarcinoma (HR = 1.05, 95% CI: 0.84–1.32) Conclusions: This review with pre-diagnostic dietary exposure showed that dietary folate intake was associated with a reduced risk of mortality of esophageal squamous cell carcinoma, whereas alcohol consumption was associated with an increased risk More studies are needed to investigate effect of dietary factors, especially postdiagnosis dietary consumption, on esophageal cancer prognosis Keywords: Dietary intake, Esophageal Cancer, Mortality, Systematic review, Meta-analysis * Correspondence: liuxudong@mail.sysu.edu.cn Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China Full list of author information is available at the end of the article © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data Sun et al BMC Cancer (2020) 20:287 Background Esophageal cancer (EC) is one of the most malignant tumors worldwide, ranking seventh in cancer incidence and sixth in cancer mortality in 2018 [1] Esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC) are two main histological types EAC is the main histological type in developed countries whereas ESCC predominates in eastern Asia and Africa [2] The prognosis of esophageal cancer is poor; the 5year survival rate of EC in the United States is 19%, in Europe 12.4%, and in China 20.9% [3–5] The prognosis of esophageal cancer is influenced by many different factors [6] Noteworthy, increasing evidence is highlighting the pivotal effects of nutritional factors on cancer prognosis and survival: natural ingredients such as lycopene and beta-carotene in the plant food could inhibit EC109 cell viability [7], dietary interventions could improve diet quality in cancer survivors [8], and nutritional support could improve esophageal cancer prognosis by improving treatment compliance, reducing toxicity and enhancing the immune response [9] However, most studies focused on the roles of perioperative nutrition support in postoperative complications [10, 11], and the results from epidemiological studies on the associations between dietary factors and EC prognosis are inconclusive [12–15] A meta-analysis showed that pre-diagnosis alcohol drinking increased risk of death in ESCC rather than in EAC [16], however, some new evidence has emerged after this study published and the pooled results are needed to be updated Therefore, by summarizing the results of observational studies, this systematic review and meta-analysis was conducted to evaluate the association between food and its components intake and risk of mortality among patients with esophageal cancer, with addressing the difference in histology and the difference between allcause mortality and cancer-specific mortality Methods Literature search Literatures published up to October 2019 were systematically searched through four English databases (PubMed, Web of Science, OVID, ProQuest) and two Chinese databases (CNKI and Wanfang) PRISMA statement for conducting and reporting meta-analysis of observational studies was followed [17] The search strategy was as follows: [(vegetables OR fruits OR meat OR poultry OR drinking OR alcohol OR beer OR liquor OR beverage OR nuts OR soy OR cereal OR bean OR nutrients OR micronutrients OR macronutrients OR dietary fiber OR vitamin OR phytochemicals OR lignan OR phytoestrogen OR dietary OR diet OR food OR dietary pattern OR dietary supplements)] AND [(esophageal cancer OR esophageal adenocarcinoma OR esophageal squamous cell carcinoma Page of 13 OR esophageal neoplasm OR esophageal tumor OR cancer of esophagus OR esophageal neoplasms)] AND [(Survival OR prognosis OR mortality OR recurrence OR replase OR progression OR medical futility OR treatment outcome OR treatment failure OR cause of death OR fatal outcome)] Language and countries were not restricted during the whole searching process Two researchers (LP Sun & LB Yan) independently conducted the literature retrieval, identified potential studies, extracted information from the included papers, and assessed the quality of included studies Discrepancies were settled down by group discussion with other two professionals (X LIU & CX Zhang) The titles and abstracts of initially identified papers were firstly reviewed, and then the full texts of the selected papers were reviewed to determine eligibility To avoid omission of literatures, backward and forward citation tracking in both Web of Science and Scopus were also used to identify articles Study selection criteria Studies meeting the following conditions would be included: (i) study design was cohort study with esophageal cancer patients; (ii) the consumption of food and/or its components but not supplementations was accessible; (iii) prognostic outcomes included all-cause mortality, esophageal cancer-specific mortality or esophageal cancer recurrence; (iv) the hazard ratio (HR) or relative risk with 95% confidence interval (95% CI) were reported or could be calculated When there were papers from the same study or covering the same population, only the most comprehensive or latest data was selected Case reports, cross-sectional studies, editorials, abstracts, reviews, articles without full text, duplicated studies, animal studies and vitro studies were excluded Data extraction Data and information were extracted from the included studies, including name of the first author, publication year, country, sources of patients, sample size, histological type, follow-up duration, stage/grade grouping, dietary exposure, dietary assessments, outcomes, comparison method, effect size, confounders and covariates Quality assessment Quality of the included papers was evaluated according to the Newcastle-Ottawa Scale (NOS) Criteria for nonrandomized studies [18] A maximum total points were assigned to each study, with a maximum of for selection, for comparability and for outcome Studies were considered to be of high quality (> 6), median quality (4~6) or low quality (≤3, [19]) Sun et al BMC Cancer (2020) 20:287 Statistical analyses Meta-analysis was conducted to estimate the pooled HR with 95% CI by comparing the highest with the lowest categories of dietary intake in each selected item A random effect model was selected in the meta-analysis [20] Heterogeneity between studies was measured using Q and I2 statistics Sensitivity analysis was conducted by excluding the study one by one from the pooled results, by excluding the studies not reporting adjusted effects, and by excluding the studies not collecting information of stage and severity of esophageal cancer The metaanalysis with crude HRs obtained from univariate analysis was also conducted Publication bias was tested by funnel plot with Begg’s tests [21] A power calculator used to estimate statistical power of meta-analyses [22] Statistical analysis was completed in Stata 15.1 (Stata Corporation, College Station, TX) and R software (version 3.5.3) Results Literature retrieval Figure shows the flowchart of literature selection After removal of 4215 duplicates, 3795 potentially eligible records were left, of which 3677 were excluded after reviewing the titles and abstracts Finally, 15 eligible cohort studies [12–15, 23–33] containing 6826 esophageal cancer patients were identified through full text review of 118 studies The most common reasons for exclusion were study designs, lack of data on dietary exposure and no outcomes of interest Characteristics of included studies Characteristics and study quality of the included studies are shown in Table Briefly, cohort studies recruited patients from completed case-control studies [12–14, 23, 29, 31, 32] and the other eight were new established cohorts [15, 24–28, 30, 33]; three studies were conducted in USA [12, 13, 23], six in China [15, 24, 25, 27, 30, 32], two in Australia [29, 31], one in South Korea [28], one in Sweden [14], one in Japan [26] and one in Iran [33]; one study only recruited male patients [28] and the others included both genders The median follow-up duration ranged from 0.8 to 12.1 years Only three studies reported the risk estimates without any adjustments [23–25], other 12 studies reported adjusted risk estimates The most common adjusted confounders included age, gender, tumor stage, complications and treatments With the exception of five studies [23–25, 28, 30], other ten studies collected information of stage and severity of esophageal cancer and adjusted for them when estimating the effect size Eleven studies focused on ESCC [13–15, 23–27, 29, 30, 32], on EAC [12–14, 23, 31], and on EC [12, 28, 33] Page of 13 All of 15 included studies provided pre-diagnosis dietary exposure information In terms of types of dietary exposure, 12 studies were on alcohol consumption [14, 15, 23–29, 31–33], two on dietary folate intake [24, 25], one on sugary beverage [12], one on flavonoids and lignans [13] and one on preserved vegetables [30] A total of 13 studies [12–15, 23, 26–33] used all-cause mortality as outcome and the other two [24, 25] used esophageal cancer-specific mortality Consumption of alcohol was measured using health behavior questionnaires, while intakes of dietary folate, flavonoids, preserved vegetables and sugary beverages were collected from validate modified food frequency questionnaire Of the five studies not collecting information of stage and severity of esophageal cancer, one was focused on preserved vegetables [30] and the other four on alcohol [23–25, 28] For study quality of 15 included studies, average NOS score was 6.65, ranging from to 8; 12 studies were high quality (NOS score ≥ 7) and three studies were median quality Dietary folate intake Only two studies [24, 25] reported effects of dietary folate intake on esophageal cancer-specific mortality in ESCC These two studies provided adjusted risk estimates from multivariate analysis Categorization of folate intake was different in these two studies The highest vs the lowest in one article [24] was ≥95.5 μg/day vs < 30.0 μg/day, while in another article [25] was > 300μg/day vs < 230μg/day When pooled these two studies (Fig 2), the overall HR was 0.41 (95% CI: 0.25–0.69) with low statistical heterogeneity (Pfor heterogeneity = 0.79, I2 = 0%) The funnel plot did not reveal asymmetry (Fig 3) and the corresponding Begg’s test did not show publication bias (P = 1.00) Power calculation for random effect model was 96.5% Other dietary components Only one study on sugary beverages [12], one on phytochemicals [13] and one on preserved vegetables [30] were found Miles et al [12] studied effects of sugary beverages intake on prognosis of EC and EAC They found that soft drinks and fruit juices intake would worsen prognosis of EC patients; however, when the study population was restricted to patients with EAC, no significant association between sugary beverages and allcause mortality was found Petrick et al [13] studied effects of consumption of total dietary flavonoids, dietary flavonoid subclasses (anthocyanidins, flavan-3-ols, flavanones, flavones, flavonols and isoflavones) and lignans on all-cause mortality in ESCC and EAC, respectively; however, only lignans was found to reduce all-cause mortality of ESCC by 42% (HR = 0.58, 95% CI: 0.37– 0.92) As indicated in a study done by Shi et al [30], in ESCC patients, when comparing with patients Sun et al BMC Cancer (2020) 20:287 Page of 13 Fig Flowchart of the literature selection Abbreviation: WOS, Web of Science; HR, hazard ratio; RR, relative risk; OR, odd ratio; EC, esophageal cancer; ESCC, esophageal squamous cell carcinoma; EAC, esophageal adenocarcinoma CNKI and Wanfang are Chinese database, CNKI: http://new oversea.cnki.net/index/; Wanfang: http://www.wanfangdata.com.cn/resource_nav/index.do consuming preserved vegetables < time/week, those who consumed preserved vegetables ≥1time/week had a 1.58-fold (95% CI: 1.01–2.47) risk of all-cause mortality Alcohol consumption A total of ten studies [14, 15, 23, 26–29, 31–33] investigated effects of alcohol consumption on all-cause mortality and the other two studies [24, 25] on esophageal cancer-specific mortality (Table 1) The reference group (the lowest group) in nine studies [14, 15, 23–25, 27, 28, 32, 33] was non-drinkers, in two studies [29, 31] was those consuming < 10 g ethanol per week, and in one study [26] was non-heavy drinkers The highest group was defined as ever drinkers [23, 24], or current drinkers [15, 32, 33], or group with the highest level of alcohol consumption [14, 25–29, 31] Only five studies [23–26, 29] was available to estimate the risk by using univariate analysis (Table 2) The pooled results of the association between alcohol consumption and risk of death among different subtypes of esophageal cancer are shown in Fig When comparing the highest with lowest consumption of alcohol, the pooled HR was 1.48 (95% CI: 1.19–1.84) with low statistical heterogeneity (Pfor heterogeneity = 0.35, I2 = 4.2%) in EC and 1.29 (95% CI: 1.07–1.55) with moderate statistical heterogeneity (Pfor heterogeneity = 0.03, I2 = 53.0%) in ESCC, whereas no association was found in EAC (HR = 1.05, 95% CI: 0.84–1.32) The funnel plots did not show Median: 108 EC 274 EAC 191 ESCC Number and type of patients Well Primary invasive cases: localized, regional, distant, unknown Stage/grade grouping Dietary assessments Sugary beverages Each were divided into categories (mg/ day): Total flavonoids: 0–62.35, 62.36–103.39, 103.40–253.24, ≥253.25; Anthocyanidins: 0–6.23, 6.24–10.11, 10.12–16.23, ≥16.24; Flavan-3-ols: 0–10.90, 10.91–26.67, 26.68–210.51, ≥210.52; Flavanones: 0–8.63, 8.64–32.94, 34.95–49.00, ≥49.01; Flavones: 0–1.20, 1.21–1.81, 1.82–2.64, ≥2.65; Flavonols: 0–8.16, 8.17–12.30, 12.31–19.34, ≥19.35; Isoflavones: 0–0.31, 0.32–0.46, 0.47–0.62, ≥0.63; Lignans: 0–0.044, 0.045–0.060, 0.061–0.079, ≥0.080 Comparison categories Adjustments Age, sex, ethnicity, All-cause Cancer stage and dietary mortality energy intake For EAC: Total flavonoids: 0.98 (0.68, 1.41); Anthocyanidins: 0.87 (0.60, 1.26); Flavan-3-ols: 0.93 (0.65, 1.33); Flavanones: 1.15 (0.79, 1.68); Flavones: 0.83 (0.58, 1.19); Flavonols: 0.94 (0.65, 1.37); Isoflavones: 0.75 (0.49, 1.13); Lignans: 0.78 (0.54, 1.14) For ESCC: Total flavonoids: 0.91 (0.58, 1.44); Anthocyanidins: 2.272 (0.66, 1.56); Flavan-3-ols: 1.09 (0.69, 1.74); Flavanones: 1.24 (0.76, 2.03); Flavones: 2.272 (0.64, 1.54); Flavonols: 0.93 (0.61, 1.40); Isoflavones: 0.97 (0.60, 1.58); Lignans: 0.61 (0.39, 0.96) Adjusted HR (95% CI) (highest vs lowest) for mortality NCI-block FFQ Median for soft All-cause Total flavonoids, six A 104-item classes of flavonoids modified FFQ (anthocyanidins, flavan-3ols, flavanones, flavones, flavanols, and isoflavones), lignans Exposure NOS stars (2020) 20:287 Population-based Miles Follow-up duration (years) Max: 7.5 Mediana: 0.8 for EAC, 0.9 for ESCC Sources of cohort patients Petrick Population-based et al [13], case–control study 2015, USA Author, reference, year, country Table Characteristics of included studies and quality score Sun et al BMC Cancer Page of 13 Median: 3.25, (Min-Max: 0.25–5) Max: 7.5 293 EAC Median a: 220 ESCC 0.8 for EAC and 0.9 for ESCC Mean:2.05 (Max:6.8) Jing et al A new established [25], 2012, patient cohort China Trivers population- based, et al [23], case-control study 2005, USA Park et al [28], 2006, South Korea T stage: T1~T4 N stage: N0, N1 M stage: M0, M1 167 ESCC Folate Folate Not collected Alcohol Incident invasive Alcohol cases: localized, regional, distant, unknown T stage: T1~T4 N stage: N0, N1 M stage: M0, M1 clinical stage: 1/ 2, 3/4 120 ESCC patients underwent esophagectomy 272 EC including soft drinks and fruit juices (classified into SB1 and SB2b) Exposure AJCC stage: Only Preserved vegetables included I and II stage differentiated, Poorly differentiated, Undetermined Stage/grade grouping A selfadministered questionnaire Baseline interviews A 65-item selfadministered structured questionnaire NIH-modified FFQ A modified FFQ Dietary assessments categories(g of alcohol/ week): 0, categories: non-drinkers and ever drinkers c categories(ug/ day): < 230, 230–300, > 300 categories(ug/ day): < 30.0, 30.0–95.4, ≥95.5 All-cause mortality 1.44 (0.81,2.55) All-cause mortality d: EAC: 1.08 (0.81,1.44) ESCC: 1.77 (0.93,3.35) Cancer-specific mortality: 0.45 (0.18,0.87) Cancer-specific mortality 0.39 (0.20,0.78) All-cause mortality 1.58 (1.01,2.47) mortality For EC: soft drinks: 2.29 (1.32,3.93); fruit juices: 2.39 (1.34,4.30); SB1: 2.58 (1.45,4.60); SB2: 1.94 (1.06,3.53) For EAC: soft drinks: 1.84 (0.92,3.68); fruit juices: 1.60 (0.79,3.25); SB1: 1.51 (0.72,3.16); SB2: 1.44 (0.57,3.62) drinks and fruit juices(g/day): soft drinks:4.0; fruit juices:0.71 SB1 intake quartile point(g/day): (Q1)0.71, (Q2)11.81, (Q3) 40.00; SB2 intake quartile points(g/day) (Q1)3.04, (Q2)20.76, (Q3)45.29 categories (time/week): < and ≥ Adjusted HR (95% CI) (highest vs lowest) for mortality Comparison categories 7 NOS stars Age, BMI, fasting serum glucose level, cholesterol level, physical activity, food preference, blood None Age, sex, smoking, drinking, tumor sites, TNM stage, chemo-therapy and radio-therapy Age, sex, TNM stage Age and sex education, smoking, alcohol drinking, caloric intake, pathology type, and tumor differentiation grade Adjustments (2020) 20:287 A cohort of male participated in a national health examination program Median: 3.5, (MinMax: 0.03– 4.66) Lu et al A new established [24], 2011, patient cohort China 185 ESCC Median: 4.08 74 EAC Number and type of patients Shi et al A new established [30], 2018, patient cohort China Follow-up duration (years) 12.1 Sources of cohort patients et al [12], case–control study 2016, USA Author, reference, year, country Table Characteristics of included studies and quality score (Continued) Sun et al BMC Cancer Page of 13 Median: 6.4 (Min-Max: 4.8–8.9) Population-based case-control study Thrift et al [31], 2012, Australia Prospectively created Median:5.3 2151EC esophageal carcinoma 1851 ESCC, 718 ESCC 362 EAC 301 ESCC 167 ESCC 120 ESCC patients underwent esophagectomy Exposure A 65-item selfadministered structured questionnaire Risk factor questionnaire HERPACC questionnaire Computeraided face-toface interview with separate questions Questionnaire completed at the time of diagnosis Dietary assessments AJCC stage: + I, Alcohol (including wine, II, III spirit and beer) Baseline interviews A standardized questionnaire Alcohol (including light A health and beer, regular beer, white life style questionnaire wine, red wine, port/ sherry and spirits/liqueur) Alcohol (including light A health and beer, regular beer, white life style wine, red wine, port/ questionnaire sherry and spirits/liqueur) Alcohol Alcohol Alcohol Alcohol (including beer, wine and liquor) AJCC stage: I + II, Alcohol III + IV AJCC stage: I, II, III, IV AJCC stage: I, II, III, IV T stage: T1~T4 N stage: N0, N1 M stage: M0, M1 T stage: T1~T4 N stage: N0, N1 M stage: M0, M1 clinical stage: 1/ 2, 3/4 UICC stage: I, II, III, IV TNM stage: I, II, III, IV Differentiation: Alcohol well, moderate/ poor, nondifferentiated Stage/grade grouping All-cause mortality EAC:1.0 (0.5,1.7) ESCC:0.6 (0.3, 1.4) All-cause mortality: 7.51(0.82,69.10) Adjusted HR (95% CI) (highest vs lowest) for mortality All-cause mortality EAC: 1.02(0.64, 1.64) All-cause mortality: 1.30(1.01,1.67); All-cause mortality d: categories(g of ethanol/ week) < 10, 10–60, 70–200, ≥210 categoriesg: users and nonusers categoriesh (g of alcohol/ 7 Age, sex, weight loss, stage, radicality of surgery, Age, sex, education levels and AJCC stages Age, sex, AJCC stage, treatment intent, number of comorbidities and smoking Age, sex, AJCC stage, treatment intent, number of comorbidities and smoking None categoriesf (g Cancer-specific of ethanol/ mortality: week): never, 1.42(0.83,1.84) former, moderate, heavy Age, sex, smoking, ECOG PS, tumor length, UICC stage, treatment Age, sex, educational level, symptomatic reflux, BMI, smoking, physical activity, tumor stage and for esophagectomy None categories(g All-cause of ethanol/ mortality ESCC: week) < 10, 10– 2.08 (1.18,3.69); 60, 70–200, ≥210 NOS stars Age, sex, residence, treatment, smoking, opium use, differentiation, education pressure, and other comorbidities Adjustments Cancer-specific mortality: 1.02(0.61–1.72) categories: Never drinkers and ever drinkers categoriese (g All-cause of ethanol/ mortality week): 70 categories: no and yes 0–124.1, ≥124.2 Comparison categories (2020) 20:287 Huang et al [27], Max: Median: 6.4 (Min-Max: 4.8–8.9) Population-based case-control study Thrift et al [29], 2012, Australia Wu et al Hospital-based case[32], 2013, control study China 177 EAC 159 ESCC 122 EC Number and type of patients Median:5.6 363 ESCC (Min-Max: 2.1–7.9) Median: 3.25 (Min-Max: 0.25–5) Patients in Aichi Cancer Center Hospital Shitara et al [26], 2010, Japan From 1994.12.1– 1997.12.31 to 2004.12.31 Jing et al Patients in General [25], 2012, Hospital of Chengdu China Military Area Nationwide casecontrol study Sundelof et al [14], 2008, Sweden Max: Median: 3.5, (MinMax: 0.03– 4.66) Patients initially diagnosed in Aras Clinic Samadi et al [33], 2007, Iran Follow-up duration (years) Lu et al A new established [24], 2011, patient cohort China Sources of cohort patients Author, reference, year, country Table Characteristics of included studies and quality score (Continued) Sun et al BMC Cancer Page of 13 database 2014, China Follow-up duration (years) 643 ESCC with negative lymphatic metastasis having undergone esophagectomy Number and type of patients Post-operation staging of AJCC stage: IA, IB, IIA Stage/grade grouping Alcohol Exposure Medical records Dietary assessments categoriesi: non-drinkers and drinkers week): 0, 0–90.09, 91– 272.09, ≥273 Comparison categories Adjustments All-cause mortality d: 1.58(1.21,2.07) Age, sex, smoking, family history, tumor location, surgery technique, postoperation staging, tumor grade EC: 1.46(1.19, adjuvant treatment, 1.79) smoking ESCC: 1.37(1.11, 1.70) Adjusted HR (95% CI) (highest vs lowest) for mortality NOS stars HR hazard ratio, CI confidence interval, NOS the Newcastle-Ottawa Quality assessment scale, EC esophageal cancer, EAC esophageal adenocarcinoma, ESCC esophageal squamous cell carcinoma, FFQ food frequency questionnaire, NCI National Cancer Institute, NIH National Institutes of Health, BMI body mass index, Min minimum, Max maximum, TNM tumor node metastasis, HERPACC Hospital-based Epidemiologic Research Program at Aichi Cancer Center, ECOG PS Eastern Cooperative Oncology Group performance status, AJCC American Joint Committee on Cancer, UICC Union for International Cancer Control a Data of median survival time Survival time in this article was defined as the time from the date of diagnosis to the date of death or last follow-up, same as the time of follow-up b SB1, Sugars from soft drinks and fruit juices (g/day); SB2, Sugars from soft drinks, fruit juices, and sugar added to tea, coffee or cereal (g/day) c Ever drinkers defined as those who had ≥1 alcoholic drink (12 oz beer, oz glass of wine, drink with hard liquor) per month for ≥6 months d The outcome was overall survival (OS) defined as the time from diagnosis through death from any causes Calculated HR was the same as that of all-cause mortality e Calculated according to definition of drinking group in this article It divided alcohol intake into categories: non-heavy drinkers and heavy drinkers f Former drinkers were those who quit drinking more than year, heavy drinkers were those who drank alcoholic beverages ≥250 g of ethanol/week while moderate drinkers were defined as drinkers consuming < 250 and > g of ethanol/week g Users were defined as those who consumed alcoholic drinks ≥1 time /week for ≥6 months h Calculated according to definition of drinking group in this article It divided alcohol intake into categories: non-drinkers, light drinkers, moderate drinkers and heavy drinkers i Patients with a present or past history of alcohol consumption were referred to as drinkers Ma et al Esophageal cancer Median: [15], 2016, database of the 6.5 (MinChina Department of Max:1–20) Thoracic Surgery at Sun Yat-sen University Cancer Center Sources of cohort patients Author, reference, year, country Table Characteristics of included studies and quality score (Continued) Sun et al BMC Cancer (2020) 20:287 Page of 13 Sun et al BMC Cancer (2020) 20:287 Page of 13 Fig Forest plot of association between dietary folate intake (highest vs lowest) and esophageal cancer-specific mortality among patients with esophageal squamous cell carcinoma significant asymmetry for any types of esophageal cancer (Fig 5), and the corresponding Begg’s tests did not show publication bias (all P > 0.30) Power calculation for these three random effect models was all equal to 100.0% The sensitivity analysis was only performed on alcohol consumption The analysis was repeated consecutively by removing one study from the pooled results each time, and significant change was observed only after the exclusion of Huang’s study [27] in EC and ESCC, respectively (Supplementary Fig S1); the analysis was also conducted by excluding studies [23–25] not reporting adjusted effect size, and the pooled results were 1.26 (95% CI: 1.01–1.60) for ESCC and 1.01(95% CI: 0.70– 1.47) for EAC (Table 2) When the unadjusted effect was considered, the pooled HR was 1.27 (95% CI: 1.06–1.53) for ESCC Only one study [23] on EAC provided crude effect; hence, the pooled analysis was not conducted (Table 2) When the studies which did not include information of stage and severity of esophageal cancer were excluded, the pooled HR was 1.26 (95% CI: 1.01–1.60) for ESCC and 1.01(95% CI: 0.70–1.47) for EAC Discussion As far as we know, there lacks of systematic review with quantitative analysis to evaluate ordinary dietary Fig The funnel plot with Pseudo 95% confidence limits on dietary folate intake and esophageal cancer-specific mortality among patients with esophageal squamous cell carcinoma behavior and prognosis of esophageal cancer The results from meta-analysis displayed that pre-diagnostic dietary folate intake was significantly related to a decreased risk of esophageal cancer-specific mortality in ESCC and prediagnostic alcohol consumption was associated with an increased risk of all-cause mortality in EC and in ESCC Alcohol is one of the major determinant factors for developing esophageal cancer [34], but effects of it on esophageal cancer prognosis remain controversial [16] The pooled results in our study showed that prediagnostic alcohol consumption could increase risk of mortality among EC and ESCC patients by 48 and 29% respectively; however, this effect was not found in EAC patients Without adjustments, confounding factors could lead to misinterpretation of the association between independent variables and dependent variables [35] Hence, we pooled crude HRs obtained from univariate analysis and adjusted HRs obtained from multivariate analysis, respectively; the association remained the same, further suggesting the strong effects of alcohol intake on ESCC mortality and indicating that our results was stable and robust Similar results were obtained when the studies not including information of stage and severity of esophageal cancer were excluded The findings from our study are consistent with the results from a previous meta-analysis by Fahey et al [16], though the contrast groups were different between two studies To examine the robustness of our results, we repeated the analysis by excluding the study one by one from the pooled results, and no significant change was observed for ESCC and EAC with the exception of excluding the study by Huang et al [27], indicating the results our study obtained were stable Omitting the study by Huang et al [27] altered the positive association between alcohol consumption and risk of death in EC and ESCC to no association This may be due to that the sample size of this study was the largest, therefore the weight of the study was relatively large when calculating the pooled results, indicating that more studies with large scale samples are needed Our results of meta-analysis also indicated that intake of dietary folate was associated with 59% reduced risk of esophageal cancer-specific mortality among ESCC patients Sun et al BMC Cancer (2020) 20:287 Page 10 of 13 Table Hazard ratios (HRs) with 95% confidence intervals (CIs) for alcohol consumption and mortality of esophageal cancer by histological type Study ID a Crude HR (95% CI) b Adjusted HR (95% CI) b EC Huang et al [27] 1.46 (1.19,1.79) Samadi et al [33] 7.51 (0.82, 69.10) Park et al [28] 1.44 (0.81, 2.55) pooled estimates 1.48 (1.19, 1.84) ESCC Huang et al [27] 1.37 (1.11, 1.70) Ma et al [15] 1.58 (1.21, 2.07) Shitara et al [26] 0.87 (0.65, 1.17) Sundelof et al [14] 2.51 (1.63, 3.85) Trivers et al [23] 1.77 (0.93, 3.35) Wu et al [32] P / / 77.8 0.001 / / I2 (%) P 4.2 0.352 66.9 0.010 0.0 0.960 0.85 (0.61, 1.18) 2.08 (1.18, 3.69) 1.42 (0.83, 1.84) 1.02 (0.61, 1.72) pooled estimates 1.27 (1.06, 1.53) 1.26(1.01, 1.60) EAC Sundelof et al [14] 1.00 (0.50, 1.70) Thrift et al [31] pooled estimates I2 (%) 1.30 (1.01, 1.67) Lu et al [24] Trivers et al [23] Heterogeneity for pooled adjusted HR 0.60 (0.30, 1.40) Thrift et al [29] Jing et al [25] Heterogeneity for pooled crude HR 1.02 (0.64, 1.64) 1.08 (0.81, 1.44) 1.01 (0.70, 1.47) EC esophageal cancer, ESCC esophageal squamous cell carcinoma, EAC esophageal adenocarcinoma, HR hazard ratio, CI confidence interval b The effect was estimated by comparing the highest with the lowest consumption of alcohol a Fig Forest plot of association between alcohol consumption (highest vs lowest) and risk of mortality by cancer type Abbreviation: EC, esophageal cancer; EAC, esophageal adenocarcinoma; ESCC, esophageal squamous cell carcinoma Sun et al BMC Cancer (2020) 20:287 Page 11 of 13 Fig The funnel plot with Pseudo 95% confidence limits on alcohol consumption and risk of mortality by cancer type This finding is consistent with findings on other cancers [36, 37] Folate metabolites have become diagnostic and therapeutic targets for several types of cancers in recent years [38, 39] The possible mechanism maybe due to that folate deficiency indirectly affects DNA and RNA methylation, thereby alters the expression of tumor suppressor genes and proto-oncogenes [40, 41] However, only two studies focused on effects of dietary folate intake on EC mortality, and all were carried out in China with small sample size Thus, replication of our results in other large studies in different countries is warranted The evidence for other dietary components is limited Lignans was found to reduce risk of all-cause mortality of ESCC by 42% [12], while positive association between the other two factors, sugary beverages and preserved vegetables, and esophageal cancer survival was revealed [13, 30] Sugar in food can lead to awful disease progression through increased inflammation The inflammation can be caused by oxidative stress, which ultimately accelerates DNA damage and elevates levels of interleukin-cytokines and other pro-inflammatory molecules [42] N-nitroso compounds widely existing in processed foods (eg preserved vegetables) may play an important role in tumor progression N-nitroso compounds give rise to excessive expression of cyclinE 1, cyclinD 1, transform growth factor α and epidermal growth factor receptor in esophageal tissues, thus enhance cancer progression [43] Anti-cancer effects of phytochemicals like lignans are mainly through estrogen/anti-estrogen activity, anti-proliferation or apoptosis, prevention of oxidation, induction of cell cycle arrest, regulation of changes in host immune system, anti-inflammatory activity and cell signal transduction [44] This study has some strengths First, the literature retrieval was from multiple databases and the selection was determined by independent reviewers, which was helpful to avoid literature omission Second, we included studies according to the strict inclusion and exclusion criteria, which may augment the validity of our findings Third, sensitivity analyses yielded similar results, indicating the stability of our findings Sun et al BMC Cancer (2020) 20:287 There were also some limitations in this study There were only 15 studies included; most of them focused on alcohol consumption and only five focused on other dietary components; pooling results from limited evidence may influence the stability of our results, though the power of random effect models in our study is fairly strong and sensitivity analyses yield similar results Consuming large amounts of fruits and vegetables after diagnosis could reduce the mortality of cancer and diets before diagnosis may reflect the changes in taste or appetite attributable to cancer [45] Besides, cancer patients may follow the doctor’s advice to change their diets in order to obtain better prognosis However, dietary behaviors in this systematic review and metaanalysis were all pre-diagnostic, the roles of postdiagnostic dietary intake in prognosis of esophageal cancer are unclear Conclusion In summary, this review with limited evidence suggested that folate intake was associated with a reduced risk of esophageal cancer-specific mortality for ESCC, whereas alcohol consumption was associated with increased risk of mortality for ESCC More studies are needed to investigate effect of dietary factors, especially post-diagnosis dietary consumption, on esophageal cancer prognosis Supplementary information Supplementary information accompanies this paper at https://doi.org/10 1186/s12885-020-06767-8 Additional file 1: Figure S1 Summary of sensitivity analyses of alcohol consumption and mortality among (a) EC (b) ESCC (c) EAC Abbreviation: HR, hazard ratio; CI, confidence interval; EC, esophageal cancer; EAC, esophageal adenocarcinoma; ESCC, esophageal squamous cell carcinoma Abbreviations CI: Confidence interval; EC: Esophageal cancer; ESCC: Esophageal squamous cell carcinoma; EAC: Esophageal adenocarcinoma; HR: Hazard ratio HR; NOS: Newcastle-Ottawa Scale Acknowledgments We would like to show our thanks to the authors of original published researches; their work achievement is the precondition of our study Authors’ contributions XDL conceived and designed this study; LPS, LBY, and ZZL conducted the research, including the literature search, quality assessment, and data extraction; WZ and CXZ assisted with the quality assessments; LPS performed the statistical analysis; LPS and XDL wrote the manuscript; XDL, WZ, CXZ, YMC, XQL and edited and reviewed the manuscript All authors have read and approved the manuscript, and ensure that this is the case Funding This study was supported by the Guangdong Basic and Applied Basic Research Foundation (No.2019A15150115990) The funders had no role in the design, analysis, or writing of this manuscript Page 12 of 13 Availability of data and materials This study is a systematic review and meta-analysis, the data was extracted from published research The data is available by contacting corresponding author or extracting from original published research Ethics approval and consent to participate Ethical approval for this study was obtained from Ethical Review Committee for Biomedical Research, School of Public Health, Sun Yat-sen University The study was performed in accordance with the Declaration of Helsinki The study is a systematic review and meta-analysis and no patients involved Consent for publication This study did not contain any individual person’s data Competing interests All authors declared that they have no conflicts of interest Author details Department of Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou, China 2Department of Pediatric Surgery, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China 3Department of Radiology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China 4Department of Public Health, Faculty of Medicine, Hokkaido University, Sapporo, Japan 5JC School of Public Health and Primary care, the Chinese University of Hong Kong, Hong Kong, China Received: 10 November 2019 Accepted: 20 March 2020 References Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 2018;68(6):394–424 Malhotra GK, Yanala U, Ravipati A, Follet M, Vijayakumar M, Are C Global trends in esophageal cancer J Surg Oncol 2017;115(5):564–79 Siegel RL, Miller KD, Jemal A Cancer statistics, 2019 CA Cancer J Clin 2019; 69(1):7–34 Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, Holleczek B, Johnston BT, Cook MB, Bannon F, et al Survival for oesophageal, stomach and small intestine cancers in Europe 1999–2007: results from EUROCARE-5 Eur J Cancer 2015;51(15):2144–57 Zeng H, Zheng R, Guo Y, Zhang S, Zou X, Wang N, Zhang L, Tang J, Chen J, Wei K, et al Cancer survival in China, 2003–2005: a population-based study Int J Cancer 2015;136(8):1921–30 Vendrely V, Launay V, Najah H, Smith D, Collet D, Gronnier C Prognostic factors in esophageal cancer treated with curative intent Digestive Liver Disease 2018;50(10):991–6 Nguyen Ba N, Lv P, Zhao W-E Suppressive effects of lycopene and betacarotene on the viability of the human esophageal squamous carcinoma cell line EC109 Oncol Lett 2018;15(5):6727–32 Burden S, Sremanakova J, Jones D, Todd C Dietary interventions for cancer survivors Proc Nutr Soc 2018;78(1):135–45 Chen F, Fang J, Wang H, Song T, Zhu W, Wu M, Wu Y Effects of nutritional support on short-term clinical outcomes and immune response in unresectable locally advanced oesophageal squamous cell carcinoma Eur J Cancer Care 2018;27(2):e12818 10 Healy LA, Ryan A, Doyle SL, Bhuachalla EB, Cushen S, Segurado R, Murphy T, Ravi N, Donohoe CL, Reynolds JV Does prolonged enteral feeding with supplemental Omega-3 fatty acids impact on recovery post-esophagectomy results of a randomized double-blind trial Ann Surg 2017;266(5):720–8 11 Matsumoto H, Okamoto Y, Kawai A, Ueno D, Kubota H, Murakami H, Higashida M, Hirai T Prognosis prediction for postoperative esophageal Cancer patients using Onodera's prognostic nutritional index Nutrit Cancer Int J 2017;69(6):849–54 12 Miles FL, Chang SC, Morgenstern H, Tashkin D, Rao JY, Cozen W, Mack T, Lu QY, Zhang ZF Association of sugary beverages with survival among patients with cancers of the upper aerodigestive tract Cancer Causes Control 2016;27(11):1293–300 13 Petrick JL, Steck SE, Bradshaw PT, Trivers KF, Abrahamson PE, Engel LS, He K, Chow WH, Mayne ST, Risch HA, et al Dietary intake of flavonoids and Sun et al BMC Cancer 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 (2020) 20:287 oesophageal and gastric cancer: incidence and survival in the United States of America (USA) Br J Cancer 2015;112(7):1291–300 Sundelof M, Lagergren J, Ye W Patient demographics and lifestyle factors influencing long-term survival of oesophageal cancer and gastric cardia cancer in a nationwide study in Sweden Eur J Cancer (Oxford, England : 1990) 2008;44(11):1566–71 Ma Q, Liu W, Jia R, Long H, Zhang L, Lin P, Zhao H, Ma G Alcohol and survival in ESCC: prediagnosis alcohol consumption and postoperative survival in lymph node-negative esophageal carcinoma patients Oncotarget 2016;7(25):38857–63 Fahey PP, Mallitt KA, Astell-Burt T, Stone G, Whiteman DC Impact of prediagnosis behavior on risk of death from esophageal cancer: a systematic review and meta-analysis Cancer Causes Control 2015;26(10):1365–73 Moher D, Liberati A, Tetzlaff J, Altman DG, Group P Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ 2009;339:b2535 Stang A Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses Eur J Epidemiol 2010;25(9):603–5 Rotenstein LS, Ramos MA, Torre M, et al Prevalence of depression, depressive symptoms, and suicidal ideation among medical students: a systematic review and meta-analysis JAMA 2016;316(21):2214–36 Higgins JPT, Thompson SG, Deeks JJ, Altman DG Measuring inconsistency in meta-analyses BMJ (Clinical research ed) 2003;327(7414):557–60 Sedgwick P Meta-analyses: how to read a funnel plot Br Med J 2013;346: f1342 Harrer M, Cuijpers P, Furukawa TA, Ebert DD Doing Meta-Analysis in R: A Hands-on Guide 2019 https://doi.org/10.5281/zenodo.2551803 Available at https://bookdown.org/MathiasHarrer/Doing_Meta_Analysis_in_R/ Trivers KF, de Roos AJ, Gammon MD, Vaughan TL, Risch HA, Olshan AF, Schoenberg JB, Mayne ST, Dubrow R, Stanford JL, et al Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancers Clin Gastroenterol Hepatol 2005;3(3):225–30 Lu C, Xie H, Wang F, Shen H, Wang J Diet folate, DNA methylation and genetic polymorphisms of MTHFR C677T in association with the prognosis of esophageal squamous cell carcinoma BMC Cancer 2011;11:91 Jing C, Huang Z, Duan Y, Xiao X, Zhang R, Jiang J Folate intake, methylenetetrahydrofolate reductase polymorphisms in association with the prognosis of esophageal squamous cell carcinoma Asian Pacific J Cancer Prevention 2012;13(2):647–51 Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, Yokota T, Abe T, Kawai H, Tajika M, Kodaira T, et al Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study Cancer Sci 2010;101(4):1001–6 Huang Q, Luo K, Yang H, Wen J, Zhang S, Li J, Ela Bella A, Liu Q, Yang F, Zheng Y, et al Impact of alcohol consumption on survival in patients with esophageal carcinoma: a large cohort with long-term follow-up Cancer Sci 2014;105(12):1638–46 Park SM, Lim MK, Shin SA, Yun YH Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study J Clin Oncol 2006;24(31):5017–24 Thrift AP, Nagle CM, Fahey PP, Russell A, Smithers BM, Watson DI, Whiteman DC The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival Int J Cancer 2012;131(5): E759–68 Shi F, Yan F, Jin M, Chang H, Zhou Q, Zhao L, Hu Z, Song Q, Li J, He Y, et al Pre-diagnosis consumption of preserved vegetables and prognosis of invasive oesophageal squamous cell carcinoma: a prospective cohort study in one high-risk area in China J Int Med Res 2018;46(10):4306–14 Thrift AP, Nagle CM, Fahey PP, Smithers BM, Watson DI, Whiteman DC Predictors of survival among patients diagnosed with adenocarcinoma of the esophagus and gastroesophageal junction Cancer Causes Control 2012;23(4):555–64 Wu IC, Wu CC, Lu CY, Hsu WH, Wu MC, Lee JY, Chou SH, Lee JM, Chou YP, Wu DC, et al Substance use (alcohol, areca nut and cigarette) is associated with poor prognosis of esophageal squamous cell carcinoma PLoS One 2013;8(2):e55834 Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, Sadjadi A, Derakhshan MH, Shokuhi B, Fuladi R, et al Survival rate of gastric and esophageal cancers in Ardabil province, north-west of Iran Archives Iran Med 2007;10(1):32–7 Page 13 of 13 34 World Cancer Research Fund/American Insititue for Cancer Research Continuous Updated Project Expert Report 2018 Diet, Nutrition, Physical Activity and Oesophageal Cancer 2018 Available at https://www.wcrf.org/ dietandcancer/oesophageal-cancer 35 VanderWeele TJ, Shpitser I On the definition of a confounder Ann Stat 2013;41(1):196–220 36 Sato F, Ito H, Oze I, Tajima K, Watanabe M, Hosono S, Kawakita D, Tanaka H, Matsuo K, Murakami S, et al Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma Ann Oncol 2011;23(1):186–92 37 Li B, Lu Y, Wang L, Zhang CX Folate intake and breast cancer prognosis: a meta-analysis of prospective observational studies Eur J Cancer Prev 2015; 24(2):113–21 38 Konn M, Asai A, Kawamoto K, Nishida N, Satoh T, Doki Y, Mori M, Ishii H The one-carbon metabolism pathway highlights therapeutic targets for gastrointestinal cancer (review) Int J Oncol 2017;50(4):1057–63 39 Koseki J, Konno M, Asai A, Colvin H, Kawamoto K, Nishida N, Sakai D, Kudo T, Satoh T, Doki Y, Mori M, Ishii H Enzymes of the one-carbon folate metabolism as anticancer targets predicted by survival rate analysis Sci Rep 2018;8(1):303 40 Liew SC: Folic acid and diseases - supplement it or not? Revista da Associacao Medica Brasileira (1992) 2016, 62(1):90–100 41 Rai V Folate pathway gene MTHFR C677T polymorphism and risk of lung cancer in Asian populations Asian Pacific J Cancer Prevention 2014;15(21): 9259–64 42 Johnson RJ, Sanchez-Lozada LG, Nakagawa T The effect of fructose on renal biology and disease J Am Soc Nephrol 2010;21(12):2036–9 43 Liston BW, Gupta A, Nines R, Carlton PS, Kresty LA, Harris GK, Stoner GD Incidence and effects of ha-ras codon 12 G→a transition mutations in preneoplastic lesions induced by N-nitrosomethylbenzylamine in the rat esophagus Mol Carcinog 2001;32(1):1–8 44 Veeramuthu D, Raja WRT, Al-Dhabi NA, Savarimuthu I: Flavonoids: Anticancer Properties Flavonoids - From Biosynthesis to Human Health, Goncalo C Justino, IntechOpen; 2017 45 Peng C, Luo W-P, Zhang C-X Fruit and vegetable intake and breast cancer prognosis: a meta-analysis of prospective cohort studies Br J Nutr 2017; 117(5):737–49 Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations  ... intake and esophageal cancer-specific mortality among patients with esophageal squamous cell carcinoma behavior and prognosis of esophageal cancer The results from meta-analysis displayed that... OR dietary OR diet OR food OR dietary pattern OR dietary supplements)] AND [ (esophageal cancer OR esophageal adenocarcinoma OR esophageal squamous cell carcinoma Page of 13 OR esophageal neoplasm... studies with large scale samples are needed Our results of meta-analysis also indicated that intake of dietary folate was associated with 59% reduced risk of esophageal cancer-specific mortality among